Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102532245B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102532245B details a cost-effective synthesis of ursolic acid derivatives for leukemia treatment, offering significant advantages in API manufacturing efficiency.